As proof-of-principle, we tested the ability of the model to find low immunogenic constructs of the C2 domain of Factor VIII as the domain is highly immunogenic and involved in the ADA development in hemophilia A patients when used therapeutically [39, 40]. This evidence concerns the gene ADA and hemophilia A.